Tenoten in the therapy of anxious disturbances in patients with essential hypertension and coronary heart disease.
The study demonstrated high anxiolytic activity of tenoten, which was not inferior to the anxiolytic effect of grandaxin. The positive changes persisted after termination of treatment in the tenoten group (but not in grandaxin group). Tenoten can be recommended for the treatment of patients with cardiovascular diseases associated with neurotic disturbances.
Vanchakova
N P
NP
Department of Psychiatry and Narcology, I. P. Pavlov St. Petersburg State Medical University.
Popov
A P
AP
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000906:Antibodies / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy* / Q000473:pathology; D001569:Benzodiazepines / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D000906:Antibodies; D000959:Antihypertensive Agents; C529609:tenoten; D001569:Benzodiazepines; C012582:tofisopam